BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1312868)

  • 1. Antisense inhibition of oncogene expression.
    Neckers L; Whitesell L; Rosolen A; Geselowitz DA
    Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG; Moses AC
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of gene expression: a tool for studying the role of NMYC in the growth and differentiation of neuroectoderm-derived cells.
    Neckers LM; Rosolen A; Whitesell L
    J Immunother (1991); 1992 Oct; 12(3):162-6. PubMed ID: 1332744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mouse preimplantation development by epidermal growth factor receptor antibodies, antisense RNA, and deoxyoligonucleotides.
    Brice EC; Wu JX; Muraro R; Adamson ED; Wiley LM
    Dev Genet; 1993; 14(3):174-84. PubMed ID: 8358863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antisense strategies come of age].
    Yokoyama K
    Tanpakushitsu Kakusan Koso; 1993 Mar; 38(4):753-65. PubMed ID: 8475331
    [No Abstract]   [Full Text] [Related]  

  • 9. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A; Agrawal KC
    Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD
    Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
    Yang D; Li T; Xu W
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific block of androgen receptor activity by antisense oligonucleotides.
    Hamy F; Brondani V; Spoerri R; Rigo S; Stamm C; Klimkait T
    Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells.
    Oridate N; Esumi N; Lotan D; Hing WK; Rochette-Egly C; Chambon P; Lotan R
    Oncogene; 1996 May; 12(9):2019-28. PubMed ID: 8649863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
    Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F
    Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.